Tocilizumab: all 334 studies that test it
Page 4 of 4. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS StudyStatus unknownNCT01717170Phase 1/2
- Tocilizumab Effect iN pOlymyalgia RheumaticaCompletedNCT01713842Phase 2
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of ActionCompletedNCT01638715Phase 4
- Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian CancerCompletedNCT01637532Phase 1/2
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose ReductionStatus unknownNCT01491815Phase 4
- Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial InfarctionCompletedNCT01491074Phase 2
- A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT01455701Phase 1
- Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01347983Phase 3
- Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)CompletedNCT01297699Phase 3
- Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01258712Phase 3
- To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01256736Phase 3
- Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or MethotrexateCompletedNCT01245452Not applicable
- A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid ArthritisCompletedNCT01214733Phase 3
- Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01211834Phase 3
- A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra TreatmentCompletedNCT01183598Phase 1
- Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After DiscontinuationCompletedNCT01120366Phase 4
- Tocilizumab for Relapsing PolychondritisWithdrawnNCT01104480Phase 2
- Role of Interleukin-6 in ExerciseCompletedNCT01073826Not applicable
- Efficacy and Safety of Tocilizumab in Adult's Still DiseaseStatus unknownNCT01002781Phase 2
- PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)CompletedNCT00380601Phase 3
- Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNCT00144664Phase 3
- Study of MRA in Patients With Rheumatoid Arthritis (RA)CompletedNCT00144651Phase 2
- Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNCT00144625Phase 3
- Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT00144612Phase 3
- Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT00144599Phase 3
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPCompletedNCT00144586Phase 3
- Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal ImpairmentCompletedNCT00144573Not applicable
- Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)CompletedNCT00144560Not applicable
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JPCompletedNCT00144547Phase 3
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JPCompletedNCT00144534Phase 3
- Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)CompletedNCT00144521Phase 3
- Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)CompletedNCT00144508Phase 3
- A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisCompletedNCT00109408Phase 3
- A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00106574Phase 3